Cargando…
Oromucosal Administration of Interferon to Humans
The prevailing dogma is that, to be systemically effective, interferon-alpha (IFNα) must be administered in sufficiently high doses to yield functional blood concentrations. Such an approach to IFNα therapy has proven effective in some instances, but high-dose parenteral IFNα therapy has the disadva...
Autores principales: | Beilharz, Manfred W., Cummins, Martin J., Bennett, Alayne L., Cummins, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033912/ https://www.ncbi.nlm.nih.gov/pubmed/27713254 http://dx.doi.org/10.3390/ph3020323 |
Ejemplares similares
-
Low‐dose oral interferon alpha as prophylaxis against viral respiratory illness: a double‐blind, parallel controlled trial during an influenza pandemic year
por: Bennett, Alayne L., et al.
Publicado: (2013) -
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
por: Patti, F, et al.
Publicado: (2016) -
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
por: Überall, Michael A
Publicado: (2020) -
Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
por: Rodrigues, Daniela A., et al.
Publicado: (2021) -
Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic
por: Ivanova, Nadezhda, et al.
Publicado: (2022)